NCT01254604View on ClinicalTrials.gov

Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)

PHASE3CompletedINTERVENTIONAL

Enrollment

190

Participants

Timeline

Start Date

December 1, 2011

Primary Completion Date

May 9, 2013

Study Completion Date

May 9, 2013

Conditions

GlaucomaOcular Hypertension

Interventions

DRUG

Preservative-Free Tafluprost or vehicle

Preservative-free tafluprost (0.0015%) ophthalmic solution; Preservative-free vehicle ophthalmic solution (contains no active drug)

DRUG

Preservative-Free Timolol maleate

Preservative-free timolol maleate (0.5%) ophthalmic solution

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01254604 - Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) | Biotech Hunter | Biotech Hunter